Publication | Open Access
Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
30
Citations
62
References
2020
Year
This study indicate that HSD17B6 could be a new biomarker for the prognosis of HCC and an important negative regulator of immune responses in HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1